2019 ʻAno Hou 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1

ʻO ka nui o nā ʻike hoʻokele papahana a hoʻokahi wale nō i hoʻokahi kumu hoʻohālike e hana i ka mea nui o ka kamaʻilio hui a me kā mākou ʻike maʻalahi i kāu mau manaʻo no 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, mākou makemake e hāʻawi iā ʻoe i ke kumu kūʻai haʻahaʻa loa ma ka mākeke, ʻoi aku ka maikaʻi a me ka lawelawe kūʻai maikaʻi loa. Welcome e hana bussines me mākou, e lanakila pālua kāua.
ʻO ka nui o nā ʻike hoʻokele papahana a me hoʻokahi wale nō mea hoʻohālike e hoʻolako i ka mea nui o ka kamaʻilio hui a me ko mākou ʻike maʻalahi i kāu mau manaʻoKina 3-Aminopyrazine-2-Carboxylic Acid a me 5424-01-1, Ua kaulana loa kā mākou mau waiwai i ka hua'ōlelo, e like meʻAmelika Hema,'Afelika, Asia a pēlā aku.Company e "hana mua-papa huahana" e like me ka pahu hopu, a hooikaika e kaumaha aku i nā mea kūʻai mai me ka kiʻekiʻe o ka hoʻonā 'ana, hoʻolako kiʻekiʻe-koʻikoʻi ma hope o-kuai lawelawe a me ka oaoieei kākoʻo, a me ka mea kūʻai mai kekahi pomaikai, e hana i ka maikai 'oihana a me ka wā e hiki mai!

Hoʻohana ʻia ka 2'-Methoxy-3′-nitro-biphenyl-3-carboxylic acid ma ke ʻano he waena o Eltrombopag.
ʻO Eltrombopag, i hoʻomohala ʻia e GlaxoSmithKline (GSK) ma UK a ma hope i hoʻomohala pū ʻia me Novartis ma Switzerland, ʻo ia ka mea mua a ʻae wale ʻia ka mole liʻiliʻi non peptide TPO receptor agonist ma ka honua.Ua ʻae ʻia ʻo Eltrombopag e ka US FDA ma 2008 no ka mālama ʻana i ka idiopathic thrombocytopenic purpura (ITP), a ma 2014 no ka mālama ʻana i ka anemia aplastic koʻikoʻi (AA).ʻO ia ka lāʻau lapaʻau mua i ʻae ʻia e ka US FDA no ka mālama ʻana iā AA i nā makahiki he 30 i hala iho nei.
Ma December2012, ua apono ka US FDA ia Eltrombopag no ka lapaau ana i ka thrombocytopenia i na ma'i me ka ma'i hepa C (CHC), i hiki i na ma'i hepa C me ka ilihune prognosis ma muli o ka helu platelet ha'aha'a hiki ke ho'omaka a mālama i ka interferon ma muli o ka ma'i ma'i o ka ate.Ma Feberuari 3,2014, ua hoʻolaha ʻo GlaxoSmithKline ua hāʻawi ka FDA i ka hōʻailona lāʻau lapaʻau holomua o Eltrombopag no ka mālama ʻana i ka hemopenia i nā maʻi me ka puke kemika aplastic anemia (SAA) ʻaʻole i pane piha i ka immunotherapy.Ma ʻAukake 24, 2015, ua ʻae ka US FDA iā Eltrombopag no ka mālama ʻana i ka thrombocytopenia i nā pākeke a me nā keiki o 1 makahiki a ʻoi aku me ka thrombocytopenia immune maʻi (ITP) i lawa ʻole ka pane ʻana i nā corticosteroids, immunoglobulins a splenectomy.Ma Ianuali4,2018, ua ʻae ʻia ʻo Eltrombopag e papa inoa ma Kina no ka mālama ʻana i ka thrombocytopenia immune mua (ITP).

ʻO ka nui o nā ʻike hoʻokele papahana a hoʻokahi wale nō i hoʻokahi kumu hoʻohālike e hana i ka mea nui o ka kamaʻilio hui a me kā mākou ʻike maʻalahi i kāu mau manaʻo no 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, mākou makemake e hāʻawi iā ʻoe i ke kumu kūʻai haʻahaʻa loa ma ka mākeke, ʻoi aku ka maikaʻi a me ka lawelawe kūʻai maikaʻi loa. Welcome e hana bussines me mākou, e lanakila pālua kāua.
2019 ʻAno HouKina 3-Aminopyrazine-2-Carboxylic Acid a me 5424-01-1, Ua kaulana loa kā mākou mau waiwai i ka hua'ōlelo, e like meʻAmelika Hema,'Afelika, Asia a pēlā aku.Company e "hana mua-papa huahana" e like me ka pahu hopu, a hooikaika e kaumaha aku i nā mea kūʻai mai me ka kiʻekiʻe o ka hoʻonā 'ana, hoʻolako kiʻekiʻe-koʻikoʻi ma hope o-kuai lawelawe a me ka oaoieei kākoʻo, a me ka mea kūʻai mai kekahi pomaikai, e hana i ka maikai 'oihana a me ka wā e hiki mai!